Home

Many Ideal persuade tumor marker for lung ca leftovers Condense chimney

Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar
Table 2 from SRSF 5 : a novel marker for small-cell lung cancer and pleural metastatic cancer Short title : SRSF 5 protein is a new SCLC marker | Semantic Scholar

Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE
Combination of Circulating Tumor Cells with Serum Carcinoembryonic Antigen Enhances Clinical Prediction of Non-Small Cell Lung Cancer | PLOS ONE

Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE
Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers | PLOS ONE

Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports
Association of Divergent Carcinoembryonic Antigen Patterns and Lung Cancer Progression | Scientific Reports

Clinical relevance of molecular markers in lung cancer - ScienceDirect
Clinical relevance of molecular markers in lung cancer - ScienceDirect

Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine
Elevated tumor markers for monitoring tumor response to immunotherapy - eClinicalMedicine

SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo
SciELO - Brasil - Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo Marcadores moleculares no câncer de pulmão: papel prognóstico e sua relação com o tabagismo

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE
Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer | PLOS ONE

Recommendations for use of markers according to histologies of lung... | Download Table
Recommendations for use of markers according to histologies of lung... | Download Table

Useful and potentially useful markers for lung cancer. | Download Table
Useful and potentially useful markers for lung cancer. | Download Table

List of reviewed tumour markers in lung cancer | Download Table
List of reviewed tumour markers in lung cancer | Download Table

Lung Cancer | NEJM
Lung Cancer | NEJM

Tumor type and expression of markers in lung cancer cases. | Download Table
Tumor type and expression of markers in lung cancer cases. | Download Table

Oncology
Oncology

Tumor markers - Cusabio
Tumor markers - Cusabio

Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research
Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma - Chinese Journal of Cancer Research

Frontiers | Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
Frontiers | Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China

Clinical Utility of Tumor Markers
Clinical Utility of Tumor Markers

Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease
Molecular markers to predict clinical outcome and radiation induced toxicity in lung cancer - Palmer - Journal of Thoracic Disease

Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy - ScienceDirect

EPOS™
EPOS™

PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer
PDF) National Academy of Clinical Biochemistry Guidelines for the Use of Tumor Markers in Lung Cancer

CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE

Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar
Table 1 from Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE | Semantic Scholar